Quantum materials, materials exhibiting physical behavior governed by the laws of quantum mechanics, have proved promising ...

Parties discussed information provided by Newron and changes needed by FDA to consider re-start of enrollment in ENIGMA-TRS 2 ...

Newron Pharmaceuticals provides update following Type A meeting with the US FDA: Milan, Italy Saturday, July 4, 2026, 10:00 Hrs [IST] Newron Pharmaceuticals S.p.A. (Newron), a bio ...

SetPoint Medical, a commercial-stage medical technology company dedicated to improving care for people living with chronic ...

A new approach for identifying signs of hidden awareness in people who cannot speak or move after severe brain injury has ...

An analytical guide to cellular optimization, epigenetic switches, and the daily disciplines that preserve youth from the ...

Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.

You'll come for the hands-on tweaking and wealth of features, and quickly forgive some of the workflow issues when you hear ...

Conventional TIL therapy, clinically validatedrecently with the U.S. Food and Drug Administration approval of lifileucel for advanced melanoma,stillfaces substantial hurdles.

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signalling pathways to develop treatments for people living with cancer, pain, dermatologic ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today provides shareholders a ...

The wAIHA market landscape is undergoing a significant evolution after years of dependence on broad immunosuppressive ...